Company news
Shanghai Rendu Biotechnology Co., Ltd. Class A (SSE:688193) news
Shanghai Rendu Biotechnology Co., Ltd. Class A news releases on 6ix. Latest, Sep 29, 2026: (688193)"SHANGHAI RENDU BIOTECHNOLOGY CO., LTD."Announcement…
Press releases & updates
(688193)"SHANGHAI RENDU BIOTECHNOLOGY CO., LTD."Announcement on Election of Employee Representative Director for the 3rd Board of Directors
September 28, 2026
(688193)"SHANGHAI RENDU BIOTECHNOLOGY CO., LTD."Announcement on Completion of Election of New Board of Directors, Appointment of Senior Executives and Securities Affairs Representative, Designation of the Chairman to Act as the Board Secretary, and Designation of a Person to Act as the Chief Financial Officer
September 28, 2026
"SHANGHAI RENDU BIOTECHNOLOGY CO., LTD."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
September 28, 2026
"SHANGHAI RENDU BIOTECHNOLOGY CO., LTD."Announcement on Election of New Board of Directors
September 11, 2026
"SHANGHAI RENDU BIOTECHNOLOGY CO., LTD."Announcement on Resolutions of the 18th Meeting of the 2nd Board of Directors
August 28, 2026
"SHANGHAI RENDU BIOTECHNOLOGY CO., LTD."Announcement on the Completion of the Registration of Transfer of Shares under the Agreement by the Controlling Shareholder and Actual Controller and the Change in the Company's Controlling Shareholder and Actual Controller
August 13, 2026
"SHANGHAI RENDU BIOTECHNOLOGY CO., LTD."Announcement on Progress of Share Transfer by Agreement by the Controlling Shareholder and Actual Controller and Proposed Change in Control
July 27, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 3, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 21, 2026
Indicative Announcement on Proposed Change of Control Arising from the Controlling Shareholder's and Actual Controller's Agreement to Transfer Shares
May 14, 2026
Announcement on Continued Trading Suspension of Stock Trading for Event Related to Planning of Change of Control Rights by Controlling Shareholders
May 11, 2026
Announcement on Suspension of Stock Trading for Event Related to Planning of Change of Control Rights by Controlling Shareholders
May 7, 2026
Announcement on Failure to Fulfill Vesting Conditions for the 3rd Vesting Period of 2023 Restricted Stock Incentive Plan and Cancellation of Partial Restricted Shares Granted but Not Yet Vested
April 28, 2026
Announcement on Change of Sponsor Representative
April 24, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Earnings Preannouncement for 2025
January 30, 2026
Announcement on Estimated Daily Related Party Transactions in 2026
January 16, 2026
Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
December 9, 2025
Announcement on Election of Employee Director
November 25, 2025
Announcement on Implementation of Interim Dividend Distribution for 2025
November 19, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
November 17, 2025
Announcement on Change of Sponsor Representative for Continuous Supervision
November 12, 2025
Announcement on Resolutions of the 14th Meeting of the 2nd Board of Directors
October 30, 2025
Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
September 22, 2025
Announcement on Obtaining IVDR CE Certification for the Company's Products
August 29, 2025
Announcement on Vesting Results in the 1st Vesting Period of the 2023 Restricted Stock Incentive Plan and Shares Listing
July 23, 2025
Announcement on Resolutions of the 10th Meeting of the 2nd Board of Supervisors
July 2, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 20, 2025
Announcement on Reply to the Regulatory Inquiry Letter Regarding Information Disclosure of the 2024 Annual Report
June 11, 2025
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Relevant Product
May 30, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 22, 2025
Indicative Announcement on Report on Results of Shareholders' Inquiry-based Transfer and Equity Change Resulting from Share Reduction of Shareholders with Over 5% Shares to Less than 5%
May 12, 2025
Indicative Announcement on Pricing of Shareholder Inquiry-based Transfer
May 7, 2025
Shareholder's Inquiry Transfer Plan
May 6, 2025
Announcement on Resolutions of the 11th Meeting of the 2nd Board of Directors
April 29, 2025
Announcement on Listing and Circulation of Some Restricted Stocks in Initial Public Offering
March 20, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on Resolutions of the 8th Meeting of the 2nd Board of Supervisors
January 17, 2025
Announcement on Release of Pledge of Shares Held by Shareholders with Over 5% Shares
December 18, 2024
Announcement on Attending Collective Q3 Report Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2024
November 5, 2024
Report for Q3 2024
October 29, 2024
Announcement on Implementation of Semi-annual Dividend Distribution in 2024
October 21, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
September 19, 2024
Announcement on Attending 2024 Online Collective Reception Day for Investors of Listed Companies in Shanghai Jurisdiction and Semi-annual Report Performance Briefing
September 5, 2024
Announcement on Semi-annual Profit Distribution Plan 2024
August 29, 2024
Announcement on Implementation Result of Repurchasing Shares and Share Changes
August 19, 2024
Announcement on Progress in Repurchasing Shares through Call Auction
August 1, 2024
Announcement on Reaching 3% of Total Share Capital in Share Repurchase through Auction and Progress of Share Repurchase
July 24, 2024
Announcement on Criticism by Shanghai Stock Exchange for the Company and Relevant Parties
July 14, 2024
Announcement on Progress in Repurchasing Shares through Auction
July 1, 2024